DAFNA Capital Management as of June 30, 2020
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 87 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Stereotaxis Com New (STXS) | 17.6 | $61M | 14M | 4.46 | |
| Blueprint Medicines (BPMC) | 5.1 | $18M | 228k | 78.00 | |
| Fate Therapeutics (FATE) | 4.9 | $17M | 491k | 34.31 | |
| Arena Pharmaceuticals Com New | 4.5 | $15M | 245k | 62.95 | |
| Dicerna Pharmaceuticals | 3.3 | $12M | 454k | 25.40 | |
| Akebia Therapeutics (AKBA) | 3.0 | $10M | 763k | 13.58 | |
| Neurocrine Biosciences (NBIX) | 2.6 | $8.9M | 73k | 121.99 | |
| Immunomedics | 2.6 | $8.9M | 251k | 35.44 | |
| Galapagos Nv Spon Adr (GLPG) | 2.5 | $8.8M | 44k | 197.30 | |
| Dex (DXCM) | 2.5 | $8.6M | 21k | 405.38 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 2.2 | $7.5M | 1.2M | 6.08 | |
| Ishares Tr Nasdaq Biotech Etf (IBB) | 2.2 | $7.5M | 55k | 136.68 | |
| Arcturus Therapeutics Hldg I (ARCT) | 2.0 | $7.0M | 149k | 46.74 | |
| Sage Therapeutics (SAGE) | 2.0 | $6.9M | 165k | 41.58 | |
| Applied Genetic Technol Corp C | 1.9 | $6.4M | 1.2M | 5.54 | |
| Biohaven Pharmaceutical Holding | 1.8 | $6.4M | 88k | 73.11 | |
| Cara Therapeutics (CARA) | 1.8 | $6.3M | 371k | 17.10 | |
| Mersana Therapeutics (MRSN) | 1.8 | $6.3M | 270k | 23.40 | |
| AtriCure (ATRC) | 1.7 | $6.0M | 133k | 44.95 | |
| Syndax Pharmaceuticals (SNDX) | 1.5 | $5.3M | 360k | 14.82 | |
| Compugen Ord (CGEN) | 1.5 | $5.2M | 343k | 15.02 | |
| Constellation Pharmceticls I | 1.5 | $5.1M | 171k | 30.05 | |
| Luminex Corporation | 1.4 | $5.0M | 154k | 32.53 | |
| Kura Oncology (KURA) | 1.4 | $4.8M | 294k | 16.30 | |
| Cardiovascular Systems | 1.4 | $4.8M | 151k | 31.55 | |
| Liquidia Technologies (LQDA) | 1.3 | $4.6M | 550k | 8.42 | |
| Xenon Pharmaceuticals (XENE) | 1.3 | $4.3M | 347k | 12.54 | |
| Aerie Pharmaceuticals | 1.2 | $4.1M | 279k | 14.76 | |
| Affimed Therapeutics B V | 1.1 | $3.9M | 845k | 4.62 | |
| BioCryst Pharmaceuticals (BCRX) | 1.0 | $3.5M | 744k | 4.76 | |
| Alector (ALEC) | 1.0 | $3.4M | 140k | 24.44 | |
| Viking Therapeutics (VKTX) | 0.9 | $3.3M | 451k | 7.21 | |
| Radius Health Note 3.000% 9/0 (Principal) | 0.9 | $3.0M | 4.0M | 0.75 | |
| Axovant Gene The | 0.8 | $2.8M | 1.0M | 2.82 | |
| Kadmon Hldgs | 0.8 | $2.8M | 554k | 5.12 | |
| Biotelemetry | 0.8 | $2.7M | 61k | 45.19 | |
| Kalvista Pharmaceuticals (KALV) | 0.8 | $2.7M | 223k | 12.10 | |
| Mirati Therapeutics | 0.7 | $2.5M | 22k | 114.19 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 0.6 | $2.1M | 14k | 147.92 | |
| Bluebird Bio (BLUE) | 0.5 | $1.8M | 30k | 61.04 | |
| Iveric Bio | 0.5 | $1.8M | 358k | 5.10 | |
| Arcus Biosciences Incorporated (RCUS) | 0.5 | $1.8M | 72k | 24.74 | |
| Otonomy | 0.5 | $1.7M | 469k | 3.62 | |
| Larimar Therapeutics (LRMR) | 0.5 | $1.6M | 126k | 12.85 | |
| Turning Point Therapeutics I | 0.4 | $1.5M | 23k | 64.58 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.4 | $1.5M | 321k | 4.60 | |
| Harpoon Therapeutics | 0.4 | $1.4M | 85k | 16.60 | |
| Zogenix Com New | 0.4 | $1.4M | 51k | 27.02 | |
| Accuray Incorporated (ARAY) | 0.4 | $1.4M | 674k | 2.03 | |
| Johnson & Johnson (JNJ) | 0.4 | $1.3M | 9.4k | 140.64 | |
| Ardelyx (ARDX) | 0.4 | $1.3M | 185k | 6.92 | |
| Genocea Biosciences Com New (GNCAQ) | 0.3 | $1.2M | 525k | 2.30 | |
| Prevail Therapeutics Ord | 0.3 | $1.1M | 75k | 14.91 | |
| Apellis Pharmaceuticals (APLS) | 0.3 | $1.1M | 34k | 32.66 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.3 | $1.0M | 64k | 16.03 | |
| Karuna Therapeutics Ord | 0.3 | $1.0M | 9.2k | 111.47 | |
| Neuronetics (STIM) | 0.3 | $957k | 496k | 1.93 | |
| Natus Medical | 0.3 | $936k | 43k | 21.82 | |
| Hookipa Pharma Inc equity (HOOK) | 0.3 | $931k | 80k | 11.62 | |
| Corbus Pharmaceuticals Hldgs | 0.3 | $907k | 108k | 8.39 | |
| Assembly Biosciences | 0.2 | $830k | 36k | 23.33 | |
| Cerecor | 0.2 | $827k | 318k | 2.60 | |
| Soleno Therapeutics Com New | 0.2 | $827k | 373k | 2.22 | |
| Sutro Biopharma (STRO) | 0.2 | $826k | 106k | 7.76 | |
| Synlogic | 0.2 | $819k | 404k | 2.03 | |
| Morphic Hldg (MORF) | 0.2 | $812k | 30k | 27.07 | |
| Madrigal Pharmaceuticals (MDGL) | 0.2 | $747k | 6.6k | 113.18 | |
| Scpharmaceuticals (SCPH) | 0.2 | $736k | 100k | 7.36 | |
| Tcr2 Therapeutics Inc cs | 0.2 | $709k | 46k | 15.35 | |
| Masimo Corporation (MASI) | 0.2 | $684k | 3.0k | 228.00 | |
| Zymeworks | 0.2 | $651k | 18k | 36.09 | |
| Gamida Cell SHS (GMDA) | 0.2 | $640k | 140k | 4.57 | |
| Cymabay Therapeutics | 0.2 | $578k | 166k | 3.49 | |
| Leap Therapeutics | 0.2 | $575k | 275k | 2.09 | |
| Inogen (INGN) | 0.2 | $533k | 15k | 35.53 | |
| Aileron Therapeutics | 0.2 | $531k | 450k | 1.18 | |
| Nextcure (NXTC) | 0.1 | $429k | 20k | 21.45 | |
| 89bio (ETNB) | 0.1 | $408k | 21k | 19.92 | |
| Provention Bio | 0.1 | $353k | 25k | 14.12 | |
| Gritstone Oncology Ord (GRTS) | 0.1 | $332k | 50k | 6.64 | |
| Radius Health Com New | 0.1 | $300k | 22k | 13.64 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.1 | $289k | 158k | 1.83 | |
| Mereo Biopharma Group Ads (MREO) | 0.1 | $235k | 77k | 3.06 | |
| Mei Pharma Com New | 0.1 | $227k | 55k | 4.13 | |
| Aslan Pharmaceuticals Ads | 0.0 | $172k | 86k | 2.00 | |
| Lineage Cell Therapeutics In (LCTX) | 0.0 | $83k | 95k | 0.87 | |
| Cytomx Therapeutics (CTMX) | 0.0 | $51k | 6.1k | 8.36 |
